By applying linearized targeting DNA as a correction vector and ZFN as a gene scissor, Reinhardt et al. [1] genetically corrected hiPSCs derived from PD fibroblasts with LRRK2 G2019S mutation. This evidence concerns the gene LRRK2 and Parkinson disease.